AR222010A1 - Proceso para la preparacion de derivados de acidos 3-cefem-4-carboxilicos-3,7-disustituidos - Google Patents

Proceso para la preparacion de derivados de acidos 3-cefem-4-carboxilicos-3,7-disustituidos

Info

Publication number
AR222010A1
AR222010A1 AR271539A AR27153978A AR222010A1 AR 222010 A1 AR222010 A1 AR 222010A1 AR 271539 A AR271539 A AR 271539A AR 27153978 A AR27153978 A AR 27153978A AR 222010 A1 AR222010 A1 AR 222010A1
Authority
AR
Argentina
Prior art keywords
disustituidos
carboxilicos
cefem
preparation
acid derivatives
Prior art date
Application number
AR271539A
Other languages
English (en)
Original Assignee
Fujisawa Farma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9425/76A external-priority patent/GB1575803A/en
Application filed by Fujisawa Farma Co Ltd filed Critical Fujisawa Farma Co Ltd
Application granted granted Critical
Publication of AR222010A1 publication Critical patent/AR222010A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/40Unsubstituted amino or imino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/50Nitrogen atoms bound to hetero atoms
    • C07D277/52Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR271539A 1976-03-09 1978-03-27 Proceso para la preparacion de derivados de acidos 3-cefem-4-carboxilicos-3,7-disustituidos AR222010A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9425/76A GB1575803A (en) 1976-03-09 1976-03-09 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
GB4114576 1976-10-04

Publications (1)

Publication Number Publication Date
AR222010A1 true AR222010A1 (es) 1981-04-15

Family

ID=26242927

Family Applications (2)

Application Number Title Priority Date Filing Date
AR266766A AR218241A1 (es) 1976-03-09 1977-03-07 Procedimiento para obtener derivados de acidos 3-metil-7-acil-3-cefem-4-carboxilicos
AR271539A AR222010A1 (es) 1976-03-09 1978-03-27 Proceso para la preparacion de derivados de acidos 3-cefem-4-carboxilicos-3,7-disustituidos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR266766A AR218241A1 (es) 1976-03-09 1977-03-07 Procedimiento para obtener derivados de acidos 3-metil-7-acil-3-cefem-4-carboxilicos

Country Status (10)

Country Link
US (1) US4560765A (es)
AR (2) AR218241A1 (es)
CA (1) CA1218054A (es)
DE (1) DE2760288A1 (es)
DK (2) DK168863B1 (es)
ES (5) ES456625A1 (es)
HU (2) HU179016B (es)
IE (1) IE44888B1 (es)
MX (1) MX4658E (es)
SE (2) SE437832B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55406B1 (en) * 1982-08-07 1990-09-12 Tanabe Seiyaku Co Novel cephalosporin compounds and preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
SE417968B (sv) * 1972-10-20 1981-04-27 Fujisawa Pharmaceutical Co Forfarande for framstellning av penamderivat
US4113940A (en) * 1973-03-15 1978-09-12 Fujisawa Pharmaceutical Co., Ltd. 7-amino 2-lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives and processes for preparation thereof
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
GR63088B (en) * 1976-04-14 1979-08-09 Takeda Chemical Industries Ltd Preparation process of novel cephalosporins

Also Published As

Publication number Publication date
SE437832B (sv) 1985-03-18
ES476075A1 (es) 1979-05-16
AR218241A1 (es) 1980-05-30
ES476076A1 (es) 1979-05-16
ES467635A1 (es) 1979-09-01
DK139691A (da) 1991-07-25
IE44888B1 (en) 1982-05-05
CA1218054A (en) 1987-02-17
DK168863B1 (da) 1994-06-27
SE7702547L (sv) 1977-09-10
SE8302027L (sv) 1983-04-12
IE44888L (en) 1977-09-09
DK101477A (da) 1977-09-10
US4560765A (en) 1985-12-24
ES456625A1 (es) 1978-07-16
HU176455B (en) 1981-03-28
HU179016B (en) 1982-08-28
SE454988B (sv) 1988-06-13
ES476077A1 (es) 1979-05-16
DE2760288A1 (es) 1985-05-09
MX4658E (es) 1982-07-19
DK139691D0 (da) 1991-07-25
SE8302027D0 (sv) 1983-04-12

Similar Documents

Publication Publication Date Title
AR213097A1 (es) Procedimiento para preparar derivados de la 1,4-dihidropirina
AR221851A1 (es) Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina
AR211887A1 (es) Procedimiento para la preparacion de derivados de endolizina
ES495267A0 (es) Procedimiento para la obtencion de derivados de triazo- lil-a-fluorpinacolilo,acilados de efecto fungicida
AR213748A1 (es) Procedimiento para la preparacion de nuevos derivados de acidos w-aminocarboxi-w-amidoalcanosulfonicos
MX4796E (es) Procedimiento para la preparacion de derivados de 2-iminotiazolina
MX3932E (es) Procedimiento para la preparacion de 4,5-diaril-2-(tiosustituido) imidazoles
NL7714372A (nl) Fosfoncarbonzuurderivaten, alsmede werkwijze ter bereiding van dergelijke verbindingen.
ES489184A0 (es) Procedimiento para la produccion de derivados de feobromina.
AR217426A1 (es) Procedimiento para la preparacion de nuevos derivados de 7-(3-indoliloxi,naftiloxi o fenoxi-2-hidroxi-propilamino-alquil)-teofilina
DOP1977002589A (es) Procedimiento para la preparacion de nuevas tiazolinas.
AR217664A1 (es) Procedimiento para la preparacion de derivados de oleandomicina
MX144201A (es) Procedimiento mejorado para la preparacion de ciclohexanodionas (1,3)
MX3745E (es) Procedimiento para la preparacion de acido 6,11-dihidro-11-oxodibenz-(b,e)oxepin-2-alcanoico
NL7707579A (nl) Werkwijze ter bereiding van nieuwe barbituur- zuur-derivaten.
AR212174A1 (es) Procedimiento para la preparacion de derivados de las 1-aminometil-6,7-dihidroxi-1,2,3,4-tetrahidroisoquinoleinas
AR217802A1 (es) Procedimiento para la preparacion de derivados de acido 3-oxo-d-homoandrost-4-eno-17a beta-carboxilico
AR209825A1 (es) Procedimiento para la fabricacion de derivados de acido hidroxialcanoico
FR2351967A1 (fr) Procede de preparation de derives de 3-benzazepines
AR222010A1 (es) Proceso para la preparacion de derivados de acidos 3-cefem-4-carboxilicos-3,7-disustituidos
MX4834E (es) Proceso para la preparacion de 1-benzotiazolil imidazolidinonas
ES495675A0 (es) Procedimiento para preparar nuevos derivados de acidos orga-nicos.
MX4618E (es) Procedimiento para la preparacion de derivados de hidrazinopiridazina
AR218348A1 (es) Procedimiento para la produccion de acido 2,5-dicetogluconico
AR221715A1 (es) Proceso para la preparacion de derivados de tiazol